• About
  • Privacy & Policy
  • Contact Us
Procurement Nation
  • Home
  • Suppliers
  • Procurement
    • Shipping
    • Best Procurement Software
    • Supply Chain
      • What is supply chain management?
      • Tyson Foods Food Supply Chain
  • Markets
  • Banking
  • Contact Us
No Result
View All Result
  • Home
  • Suppliers
  • Procurement
    • Shipping
    • Best Procurement Software
    • Supply Chain
      • What is supply chain management?
      • Tyson Foods Food Supply Chain
  • Markets
  • Banking
  • Contact Us
No Result
View All Result
Procurement Nation
No Result
View All Result

SEC’s ‘shadow trading’ case can move forward, judge rules

Mark White by Mark White
January 18, 2022
in Supply Chain
0


  • Summary
  • Law firms
  • Related documents

  • Former pharmaceutical executive loses motion to dismiss
  • Regulator claims trades in competitor were inside trading

The company and law firm names shown above are generated automatically based on the text of the article. We are improving this feature as we continue to test and develop in beta. We welcome feedback, which you can provide using the feedback tab on the right of the page.

(Reuters) – The U.S. Securities and Exchange Commission can pursue a first-of-its-kind insider trading case accusing a former pharmaceutical company executive of trading in a competitor’s stock ahead of a merger, a judge in San Francisco ruled.

U.S. District Judge William Orrick denied Matthew Panuwat’s motion to dismiss the lawsuit on Friday. The regulator alleges Panuwat, a former business development executive at Medivation Inc, used internal knowledge of Pfizer Inc’s plan to buy Medivation to bet on the stock of fellow pharmaceutical company Incyte Corp in 2016.

An attorney for Panuwat did not immediately reply to a request for comment. He had argued the case improperly stretched insider trading law.

Register now for FREE unlimited access to Reuters.com

The case against came after researchers coined the term “shadow trading” to describe the phenomenon of insiders with non-public information trading in competitors’ or supply chain partners’ stock to evade insider trading prohibitions.

On Friday, the judge found that broad anti-fraud laws provide a basis for the SEC’s allegations that Panuwat breached a duty to his company, which had prohibited employees from using confidential information to trade.

The case is SEC v. Panuwat, U.S. District Court, Northern District Of California, No. 21-06322.

For Panuwat: Jack DiCanio of Skadden, Arps, Slate, Meagher & Flom

For the SEC: Marc Katz, David Zhou and Tracy Combs

Read more:

Exec accused of ‘shadow trading’ says case stretches law

SEC accuses pharma exec of ‘shadow trading’

Register now for FREE unlimited access to Reuters.com

Our Standards: The Thomson Reuters Trust Principles.

Jody Godoy

Jody Godoy reports on banking and securities law. Reach her at [email protected]



Source link

Previous Post

UK’s Together Energy Retail becomes latest supplier to cease trading

Next Post

Goldman Sachs earned nearly $4 billion, but that wasn’t good enough

Mark White

Mark White

Mark White is the editor of the ProcurementNation, a Media Outlet covering supply chain and logistics issues. He joined The New York Times in 2007 as an commodities reporter, and most recently served as foreign-exchange editor in New York.

Next Post
Goldman Sachs earned nearly $4 billion, but that wasn’t good enough

Goldman Sachs earned nearly $4 billion, but that wasn't good enough

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • About
  • Privacy & Policy
  • Contact Us
Call us: +1 234 JEG THEME

© 2021 Procurement Nation - Supply Chain & Logistics News

No Result
View All Result
  • Procurement
  • Supply Chain
  • Logistics
  • Science
  • Technology

© 2021 Procurement Nation - Supply Chain & Logistics News